Great Novel Therapeutics Biotech & Medicals (ROCO:7427) FCF Yield % : -3.85 (As of Jun. 15, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Great Novel Therapeutics Biotech & Medicals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Great Novel Therapeutics Biotech & Medicals's Trailing 12-Month Free Cash Flow is NT$-74.21 Mil, and Market Cap is NT$1,926.12 Mil. Therefore, Great Novel Therapeutics Biotech & Medicals's FCF Yield % for today is -3.85%.

The historical rank and industry rank for Great Novel Therapeutics Biotech & Medicals's FCF Yield % or its related term are showing as below:

ROCO:7427' s FCF Yield % Range Over the Past 10 Years
Min: -11.18 Med: -5.67 Max: -2.76
Current: -3.85

During the past 6 years, the highest FCF Yield % of Great Novel Therapeutics Biotech & Medicals was -2.76%. The lowest was -11.18%. And the median was -5.67%.

ROCO:7427's FCF Yield % is ranked better than
74.1% of 1552 companies
in the Biotechnology industry
Industry Median: -13.865 vs ROCO:7427: -3.85

Great Novel Therapeutics Biotech & Medicals's FCF Margin % for the quarter that ended in Dec. 2023 was -37,839.77%.

Great Novel Therapeutics Biotech & Medicals FCF Yield % Historical Data

The historical data trend for Great Novel Therapeutics Biotech & Medicals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Novel Therapeutics Biotech & Medicals FCF Yield % Chart

Great Novel Therapeutics Biotech & Medicals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-6.66

-4.30

-2.90

Great Novel Therapeutics Biotech & Medicals Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial					-7.41	-7.50	-5.42	-2.16	-2.60

Competitive Comparison of Great Novel Therapeutics Biotech & Medicals's FCF Yield %

For the Biotechnology subindustry, Great Novel Therapeutics Biotech & Medicals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Great Novel Therapeutics Biotech & Medicals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Great Novel Therapeutics Biotech & Medicals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Great Novel Therapeutics Biotech & Medicals's FCF Yield % falls into.

Great Novel Therapeutics Biotech & Medicals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Great Novel Therapeutics Biotech & Medicals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-74.208	/	2562.3139237
	=	-2.90%

Great Novel Therapeutics Biotech & Medicals's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-33.299	*	2	/	2562.3139237
	=	-2.60%

Great Novel Therapeutics Biotech & Medicals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Great Novel Therapeutics Biotech & Medicals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Great Novel Therapeutics Biotech & Medicals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Great Novel Therapeutics Biotech & Medicals (ROCO:7427) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.3, Park Street, Room WR-06, 17th Floor, Nangang District, Taipei, TWN, 11503

Website

http://www.gntbm.com.tw

Great Novel Therapeutics Biotech & Medicals focuses on drug development to treat advanced cancer. The new drugs ranging from epigenetic modulators, a combination of tumor microenvironment-regulating agents, epigenetic immuno-modulators, to the protein degradation drugs targeting HDACs 1, 2, and 3, are in a developing pipeline. These drugs focus on the field of epigenetics, for the demand of clinical unmet needs in advanced and refractory cancers.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Headlines

No Headlines